Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice.
Adult C3H mice which had either anagen IV or anagen VI hair follicles were given the anti-tumor drug cyclophosphamide, and cyclosporin A or minoxidil were topically applied to the mice daily from the 4th day after cyclophosphamide administration. In the mice that had anagen IV-hair follicles, 0.5% cyclosporin A induced very thick and long hairs after 21 days of cyclophosphamide administration, while vehicle and 1% minoxidil induced sparsely visible, short hairs. In the mice which received cyclosporin A, the injured hair follicles seemed to remodel themselves into intact anagen hair follicles and restart the production of hairs, instead of shifting to telogen. In the mice that had anagen VI-hair follicles at the time of cyclophosphamide administration, complete alopecia occurred within the first 7 days in all groups. After 14 days of cyclophosphamide administration, hair regrowth was observed in both the 0.5% cyclosporin A-group and the 1% minoxidil- group with the predominant effect over the vehicle. This study shows that anagen hair follicles respond to cyclophosphamide in different ways depending on their stages (IV and VI), and that the damaged anagen IV hair follicles have the potential of remodeling themselves, which is promoted by topical cyclosporin A administration.
Shirai
A
A
Kyowa Hakko Kogyo Co., Ltd., Tokyo Research Laboratories, 194-8533, Tokyo, Japan. akio.shirai@kyowa.co.jp
Tsunoda
H
H
Tamaoki
T
T
Kamiya
T
T
D000287:Administration, Topical; D000505:Alopecia / Q000139:chemically induced; D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology*; D016572:Cyclosporine / Q000494:pharmacology*; D003879:Dermatologic Agents / Q000494:pharmacology*; D006197:Hair / Q000187:drug effects / Q000254:growth & development; D018859:Hair Follicle / Q000187:drug effects* / Q000502:physiology*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008914:Minoxidil / Q000494:pharmacology
D018906:Antineoplastic Agents, Alkylating; D003879:Dermatologic Agents; D008914:Minoxidil; D016572:Cyclosporine; D003520:Cyclophosphamide